SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

HCG inks pact with Apex Criticare, Niruja, Apex HCG

03 Aug 2018 Evaluate

HealthCare Global Enterprises (HCG) has entered into a Deed of Admission and Retirement of Partner with Apex Criticare LLP (Apex Criticare), Niruja Product Development and Healthcare Research (Niruja) and Apex HCG Oncology Hospitals LLP (the LLP), on August 01, 2018, with respect to the retirement/exit of Apex Criticare as a partner in the LLP, and the consequent induction of Niruja as a new partner in the LLP.

On and from the execution date, Apex Criticare has exited from the LLP as a partner. The partners of the LLP from the Execution Date are HCG and Niruja, with a capital contribution in the ratio of 99.9% and 0.1%, respectively.

HCG is the largest provider of cancer care in India. Through its network of comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.

HealthcareGlobal Share Price

566.55 -0.25 (-0.04%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×